Examining Survival Benefits of Higher Doses of Paricalcitol in Hemodialysis Patients: Propensity Score Matching and Overadjustment Bias

Download

Miller J, Streja E, Ricks J, Norris K, Nissenson A, Kovesdy C, Kalantar-Zadeh K. Examining Survival Benefits of Higher Doses of Paricalcitol in Hemodialysis Patients: Propensity Score Matching and Overadjustment Bias. American Society of Nephrology Renal Week. San Diego, CA, Oct 27 – Nov 1, 2009.